| Drug Name: | Metaraminol (54-49-9) |
|---|---|
| PubChem ID: | 5906 |
| SMILES: | C[C@@H]([C@@H](C1=CC(=CC=C1)O)O)N |
| InchiKey: | WXFIGDLSSYIKKV-RCOVLWMOSA-N |
| Therapeutic Category: | Adrenergic Agents, Adrenergic Agonists, Adrenergic alpha-1 Receptor Agonists, Adrenergic alpha-Agonists, Autonomic Agents, Cardiovascular Agents, Neurotransmitter Agents, Peripheral Nervous System Agents, Sympathomimetics, Vasoconstrictor Agents |
| Molecular Weight (dalton) | : | 167.208 |
| LogP | : | 0.7728 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 3 |
| Hydrogen Bond Donor Count | : | 3 |
| Total Polar Surface Area | : | 66.48 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Insomnia | Mu-Type opioid receptor (P35372) | Not Available | Large-scale prediction and testing of drug activity on side-effect targets |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category